Development and clinical validation of sepsis prediction algorithm in an ICU
| Reference number | |
| Coordinator | AlgoDx AB |
| Funding from Vinnova | SEK 3 000 000 |
| Project duration | April 2020 - December 2021 |
| Status | Completed |
| Venture | Swelife and Medtech4Health - Collaborative Projects for Improved Health |
Important results from the project
Through close collaboration with researchers at Uppsala University and Skåne University Hospital in Malmö, AlgoDx has refined and clinically validated an algorithm for predicting sepsis in ICU patients (NAVOY® Sepsis, formerly known as ExPRESS).
Expected long term effects
The project completion was a necessary step in order to clinically validate the sepsis prediction algorithm at the ICU. In parallel with this project NAVOY® Sepsis has been CE-marked as a medical device software, and will be commercialized in Europe in 2022.
Approach and implementation
Despite the ongoing pandemic, AlgoDx was allowed by Region Skåne to start the planned clinical study at the ICU in December 2020. This was a crucial factor in the successful completion of the project and meeting the planned timeline.